An 80-year-old male presented with a chronic encapsulated intracerebral hematoma (CEIH) with surrounding edema under the right frontal lobe manifesting as slow exacerbation of disturbance of orientation and gait. He had a history of cerebral infarction with an asymptomatic cavernous angioma in the right frontal lobe. The CEIH was diagnosed as bleeding from the cavernous angioma, and surgical removal was performed. The hematoma was chronic and covered by a thick capsule. In addition, mass tissue covered with the organized hematoma was found near the capsule, which was excised and found to be a cavernous angioma. CEIH is a special type of intracerebral hemorrhage, and bleeding from a cavernous angioma is occasionally seen. CEIH should be considered in the case of a hemorrhagic intracranial lesion with a chronic, progressive course with capsule formation and edema around the lesion. The source of bleeding is unknown in about half of the reported cases, and occult vascular malformation may be involved, necessitating care in diagnosis.
Introduction
Intracerebral hematoma sometimes grows slowly while forming a capsule and manifesting as the symptoms of a space-occupying lesion, and is then termed a chronic encapsulated intracerebral hematoma (CEIH). We experienced a case of frontal CEIH formed by hemorrhage from a cavernous angioma, and report the pathological findings and therapeutic strategy for this disease.
Case Report
An 80-year-old man was hospitalized with right hemiparesis, as a sequela of cerebral infarction. Computed tomography (CT) showed the old cerebral infarction in the left corona radiata and a cavernous angioma of about 1-cm diameter in the right frontal lobe in March 2006 (Fig. 1) . The patient showed slowly progressive decrease in activity and disturbance of gait from the middle of April 2007, so he was hospitalized in our department.
Neurological examination on admission revealed disturbance of orientation and moderate left hemiparesis. CT revealed an intracerebral hematoma surrounded by strong edema under the right frontal lobe, and a high density region in the hematoma which appeared to have been caused by bleeding of the cavernous angioma (Fig. 2) . T 2 -weighted magnetic resonance imaging immediately after admission showed the hematoma as mixed intensities with low intensity rim suggestive of hemosiderin deposition (Fig. 3) . The hematoma was removed through a Right frontal craniotomy was performed, and the hematoma cavity was reached through the cortex. The hematoma had a thick capsule with a clear border with the surrounding tissue, and contained brownish fluid hematoma exhibiting characteristics of the chronic stage which was removed by suction. Observation of the hematoma wall revealed organized tissue with hemosiderin deposition, which was excised.
Histological examination confirmed the diagnosis of cavernous angioma. Lymphocyte infiltration from the intra-hematoma cavity side and a 3-layer structure with vascularization, including a granulomatous layer, collagenized layer, and a reactive layer of brain tissue, were observed in the hematoma capsule. Hemosiderin deposition was found around the newly formed blood vessels, suggesting that repeated bleeding from the newly formed blood vessels was involved in the growth of the hematoma (Fig. 4) .
Postoperatively, the disturbance of orientation and left hemiparesis improved, and the patient was discharged. CT showed disappearance of the hematoma and cerebral edema on discharge, and the hematoma has not recurred.
Discussion
The present case involved surgical removal of a CEIH, a cavernous angioma that developed from intracerebral hemorrhage, and a capsule formed around the hematoma by chronic progressive growth. CEIH is a special type of intracerebral hematoma described for the first time in 1981, 10) with about 50 cases reported. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] 14, 16, [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [31] [32] [33] [34] [35] [36] Compared with normal intracerebral hemorrhage, CEIH is characterized by early age of onset and rare complication by hypertension, and almost all such lesions have developed beneath the cerebral cortex. 12) Headaches and seizures are the most common earliest symptoms. Some cases have occurred in the cerebellum, 1,2,19) the basal ganglia, [11] [12] [13] [14] [15] 23) and the lateral ventricle. 17, 21, 25) In about half of cases, the cause of the initial hemorrhage is malformation of a blood vessel, and in 10 cases, including the present one, the source of bleeding was cavernous angioma (Table  1) . 18, 19, 21, 22, 24, 27, 30) Prospective study of 122 patients with intracranial cavernous angioma found the risk of hemorrhage is 2.63% per year, and the risk increases to 4.5% per year for patients with prior hemorrhage. 13) CEIH is characterized by the presence of a thick fibrotic capsule which histologically resembles the outer capsule of chronic subdural hematoma and is thought to develop by chronic progressive growth due to repeated bleeding from the new blood vessels in the capsule. 37) Vascular endothelial growth factor may be involved in the occurrence of CEIH. Further, since both leakage from the new blood vessels and strong infiltration of lymphocytes are observed, chronic inflammation reaction is involved in the edema around the hematoma. 33) Neuroimaging shows that the lesion is surrounded by marked cerebral edema and the capsule has a ring-like shape, so CEIH is often difficult to discriminate from a brain tumor. 8, 34) Definitive diagnosis requires identification of the hematoma content and hematoma capsule at surgical operation and histological diagnosis. CEIH is a benign disease with a chronic, progressive course and surgical operation often yields a good outcome. Although the 
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cause of bleeding is unknown in about half of reported cases, based on the bleeding site and common age of occurrence, it is reasonable to assume that some types of blood vessel malformation are involved. However, many cases of occult vascular malformation occur which cannot be histologically proven due to pressure from the surrounding tissues and destruction by bleeding. Therefore, the surgical treatment of this disease should achieve as complete removal of the lesion as possible including the capsule, considering the probable blood vessel malformation.
